Early T‐cell precursor acute lymphoblastic leukemia (ETP‐ALL) shows an increase in the biosynthesis of phospholipids and sphingolipids, making it particularly sensitive to inhibition of the rate‐limiting enzyme HMGCR in the mevalonate pathway. The gene discussed is HMGCR; the disease is acute lymphoblastic leukemia.